Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Epilepsy: from consensus to daily practice.

E Ben-Menachem1, B Scheepers, S Stodieck

  • 1Department of Clinical Neuroscience, Neurology Division, Sahlgrenska University Hospital, Gothenburg, Sweden. elinor.ben-menachem@neuro.gu.se

Acta Neurologica Scandinavica. Supplementum
|September 27, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.

Acta neurologica Scandinavica·2018
Same author

The effect of a multifaceted postoperative nausea and vomiting reduction strategy on prophylaxis administration amongst higher-risk adult surgical patients.

Anaesthesia and intensive care·2018
Same author

Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.

Journal of neurology·2017
Same author

Alcohol withdrawal syndrome: mechanisms, manifestations, and management.

Acta neurologica Scandinavica·2016
Same author

Long-term adjunctive lacosamide treatment in patients with partial-onset seizures.

Acta neurologica Scandinavica·2015
Same author

Surgically implanted and non-invasive vagus nerve stimulation: a review of efficacy, safety and tolerability.

European journal of neurology·2015
Same journal

Sleep quality and arousal in migraine and tension-type headache: the headache-sleep study.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Diffusion-weighted lesions in acute ischaemic stroke patients with migraine.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Mild stroke: safety and outcome in patients receiving thrombolysis.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: an overview of current knowledge.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Myasthenia gravis epidemiology in a national cohort; combining multiple disease registries.

Acta neurologica Scandinavica. Supplementum·2014
Same journal

Advances in genetic diagnosis of neurological disorders.

Acta neurologica Scandinavica. Supplementum·2014
See all related articles

Epilepsy treatment typically starts with monotherapy, with valproate being a key drug. Selecting antiepileptic drugs (AEDs) requires considering efficacy, tolerability, patient factors, and drug interactions for optimal outcomes.

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Epilepsy management emphasizes monotherapy as the initial and often preferred maintenance treatment.
  • Clinical decisions on antiepileptic drug (AED) selection necessitate robust evidence from comparative monotherapy studies and pharmacokinetic data.

Purpose of the Study:

  • To present findings from evidence-based reviews of AED monotherapy for newly diagnosed epilepsy patients.
  • To focus on treatment recommendations for valproate as a primary antiepileptic drug.
  • To discuss principles guiding AED selection in clinical practice.

Main Methods:

  • Conducted evidence-based reviews of antiepileptic drugs (AEDs) for first-line monotherapy.
  • Focused on a major UK study investigating clinical evidence for AEDs.
  • Analyzed factors influencing AED decision-making.

Related Experiment Videos

Main Results:

  • Valproate is highlighted as a mainstay antiepileptic drug (AED).
  • Evidence supports AED monotherapy for newly diagnosed epilepsy.
  • Key factors for AED selection include seizure diagnosis, tolerability, patient specifics, and drug interactions.

Conclusions:

  • Monotherapy is the standard for initiating epilepsy treatment.
  • Evidence-based reviews guide the selection of effective and tolerable AEDs.
  • Comprehensive assessment of patient and drug factors ensures optimal epilepsy management.